Related Experiment Video
Updated: Jun 22, 2026

10:08
Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
Published on: December 2, 2014
Smoking state determined by cotinine and arterial stiffness
Summary
Active smoking, confirmed by cotinine levels, significantly worsens arterial stiffness, especially with long-term exposure. Smoking impacts arterial function more severely in less developed regions.
Area of Science:
- Cardiovascular Health
- Biomarkers of Exposure
- Public Health Research
Background:
- Active and passive smoking are linked to increased arterial stiffness.
- Cotinine serves as an objective biomarker for assessing smoking status.
- Understanding smoking's impact on arterial stiffness in North China is crucial.
Purpose of the Study:
- To assess smoking conditions in North China using cotinine levels.
- To investigate the association between smoking status and arterial stiffness.
- To explore regional disparities in smoking prevalence and arterial stiffness.
Main Methods:
- Recruited 906 participants, classifying them by cotinine levels into non-smokers, passive smokers, and active smokers.
- Measured brachial-ankle pulse wave velocity (baPWV) using an automated device to assess arterial stiffness.
- Adjusted for covariates in statistical analyses to determine significant associations.
Main Results:
- Active smokers exhibited significantly higher baPWV compared to non-smokers (P=0.023).
- A smoking history exceeding 10 years was associated with higher baPWV (P=0.029).
- Less developed areas showed higher active and passive smoking rates, with active smokers having increased baPWV (P=0.017).
Conclusions:
- Cotinine-confirmed active smoking is associated with significantly worse arterial stiffness.
- Long-term smoking (over 10 years) demonstrably increases arterial stiffness.
- Smoking's detrimental effects on arterial function may be more pronounced in economically disadvantaged regions.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
